XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Collaboration, License, and Other Agreements - North America - Commercial Efforts (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Collaboration, License, Promotion and Other Commercial Agreements        
Revenue $ 113,739 $ 108,637 $ 325,182 $ 303,397
Selling, general and administrative 36,046 28,619 119,647 87,604
Collaborative arrangements, LINZESS | AbbVie Plc | U.S.        
Collaboration, License, Promotion and Other Commercial Agreements        
Selling, general and administrative $ 9,500 $ 8,900 $ 28,800 $ 26,200